Skip to Content
Clifford S Cho, MD, FACS

Contact Dr. Cho

E-mail:
cho@surgery.wisc.edu

Phone:
(608) 262-2025

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CNTR
MADISON, WI 53792-3284

Fax:
(608) 252-0913

Clifford S Cho, MD, FACS

Associate Professor
Chief, Section of Surgical Oncology
Division of General Surgery

Education

  • MD, Vanderbilt University School of Medicine, Nashville, TN, 1997
  • Internship and Residency in General Surgery, University of Wisconsin Hospital and Clinics, Madison, WI, 1997-2004
  • Research Fellowship in Transplantation Immunology, University of Wisconsin Hospital and Clinics, Madison, WI, 1999-2001
  • Surgical Oncology Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2004-2006
  • Chief Administrative Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY, 2005-2006

Research Interests

Dr. Cho conducts basic scientific research in the area of tumor immunology, investigating mechanisms by which tumors evade the host immune response.

Dr. Cho's Lab

Active Clinical Trials
  • A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute┬«-Pancreas (Algenpantucel-L) Immunotherapy in Subjects With Surgically Resected Pancreatic Cancer
    Principal Investigator(s): Clifford S Cho, MD, FACS
    Status: Active, not recruiting
    [ClinicalTrials.gov: NCT01072981]
    More Information

Recent Publications
  • A Nomogram to Predict Overall Survival and Disease-Free Survival After Curative Resection of Gastric Adenocarcinoma.
    Kim Y, Spolverato G, Ejaz A, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Levine EA, Cho CS, Maithel SK, Pawlik TM
    Ann. Surg. Oncol. 2014 Nov 12.
    [PubMed ID: 25388061]
    More Information
  • Prognostication Systems as Applied to Primary and Metastatic Hepatic Malignancies.
    Cho CS
    Surg. Oncol. Clin. N. Am. 2015 Jan; 24(1):41-56.
    [PubMed ID: 25444468]
    More Information
  • Can the Risk of Non-home Discharge After Resection of Gastric Adenocarcinoma Be Predicted: a Seven-Institution Study of the US Gastric Cancer Collaborative.
    Acher AW, Squires MH, Fields RC, Poultsides GA, Schmidt C, Votanopoulos KI, Pawlik TM, Jin LX, Ejaz A, Kooby DA, Bloomston M, Worhunsky D, Levine EA, Saunders N, Winslow E, Cho CS, Meredith K, Leverson G, Maithel SK, Weber SM
    J. Gastrointest. Surg. 2014 Nov 6.
    [PubMed ID: 25373704]
    More Information
  • Is It Time to Abandon the 5-cm Margin Rule During Resection of Distal Gastric Adenocarcinoma? A Multi-Institution Study of the U.S. Gastric Cancer Collaborative.
    Squires Iii MH, Kooby DA, Poultsides GA, Pawlik TM, Weber SM, Schmidt CR, Votanopoulos KI, Fields RC, Ejaz A, Acher AW, Worhunsky DJ, Saunders N, Levine EA, Jin LX, Cho CS, Bloomston M, Winslow ER, Russell MC, Cardona K, Staley CA, Maithel SK
    Ann. Surg. Oncol. 2014 Oct 15.
    [PubMed ID: 25316491]
    More Information
  • Conditional Survival after Surgical Resection of Gastric Cancer: A Multi-Institutional Analysis of the US Gastric Cancer Collaborative.
    Kim Y, Ejaz A, Spolverato G, Squires MH, Poultsides G, Fields RC, Bloomston M, Weber SM, Votanopoulos K, Acher AW, Jin LX, Hawkins WG, Schmidt C, Kooby D, Worhunsky D, Saunders N, Cho CS, Levine EA, Maithel SK, Pawlik TM
    Ann. Surg. Oncol. 2014 Oct 7.
    [PubMed ID: 25287440]
    More Information

webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System